Sixteen drugmakers have entered into or are negotiating confidential pricing deals with the Trump administration. Apart from the broad strokes laid out in public announcements, most details remain unknown.
President Donald Trump’s aim in making the deals is to correct the longstanding practice by pharmaceutical companies of charging Americans about three times more for prescription medications than those in other countries.
The president announced the Most Favored Nation in May, saying, “The United States will pay the same price as the Nation that pays the lowest price anywhere in the World,” in a social media post.
Six weeks later, he stated the terms of the policy in a July 31 letter to pharmaceutical companies, offering relief from certain tariffs to those who agreed to comply….
Company Filings Shed Light on Trump’s Drug Pricing Deals
